| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.3 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.4 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |